An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment

Lung cancer is the leading cause of cancer-related death worldwide. Its late diagnosis and consequently poor survival make necessary the search for new therapeutic targets. The mitogen-activated protein kinase (MAPK)-interacting kinase 1 (MNK1) is overexpressed in lung cancer and correlates with poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrión-Marchante, Rebeca, Pinto-Díez, Celia, Klett-Mingo, José Ignacio, Palacios, Esther, Barragán-Usero, Miriam, Pérez-Morgado, M. Isabel, Pascual-Mellado, Manuel, Alcalá, Sonia, Ruiz-Cañas, Laura, Sainz, Bruno, González, Víctor M., Martín, M. Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146192/
https://www.ncbi.nlm.nih.gov/pubmed/37111758
http://dx.doi.org/10.3390/pharmaceutics15041273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146192/
https://www.ncbi.nlm.nih.gov/pubmed/37111758
http://dx.doi.org/10.3390/pharmaceutics15041273

Ejemplares similares